Female Hormone Status Panel

The Female Hormone Status Panel is a blood test that provides a combined overview of several hormonal systems relevant to women’s health. It measures thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), cortisol, estrogen, progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

The panel may support the evaluation of menstrual changes, symptoms associated with thyroid function, hormonal transitions and concerns that require a broader initial hormonal overview. Symptoms such as fatigue and low energy, headaches, migraines and dizziness, weight gain and difficulty losing weight, or poor concentration and brain fog can occur with hormonal or thyroid changes, but they may also have many non-hormonal causes. The panel does not establish a diagnosis on its own.

What the panel measures

• TSH, fT3 and fT4: provide information about the signaling and hormone production involved in thyroid function.
• FSH and LH: are pituitary hormones involved in ovarian function, ovulation, menstrual-cycle regulation and the hormonal changes associated with menopause.
• Estrogen and progesterone: vary across the menstrual cycle and are interpreted according to cycle phase, reproductive stage and the reason for testing.
• Cortisol: is produced by the adrenal glands and follows a daily rhythm. It is not a standalone measure of psychological stress.

Reviewing these values together can help identify patterns that may require further assessment. A broad panel may be useful as an initial overview, but targeted testing may still be needed for fertility assessment, suspected polycystic ovary syndrome, abnormal bleeding, thyroid disease, adrenal disorders or other specific clinical questions.

When the panel may be considered

Testing may be considered when menstrual periods become irregular, unusually frequent, infrequent or absent, or when symptoms appear during perimenopause or the transition to menopause. It may also form part of an evaluation for persistent fatigue, unexplained changes in weight, altered temperature tolerance, sleep disturbance, reduced concentration or other symptoms that could involve thyroid or reproductive hormones.

Hormone measurements should be selected and interpreted in relation to the full clinical picture. Similar symptoms may occur with anemia, glucose disorders, medication effects, sleep problems, nutritional deficiencies, pregnancy, chronic stress, mental health conditions or other medical causes.

Why age, cycle phase and hormonal status matter

Age and menstrual-cycle phase

FSH, LH, estrogen and progesterone do not remain at one stable level throughout the month. Their values change between the follicular phase, ovulation and the luteal phase. The cycle day should therefore be recorded whenever menstruation is present.

FSH and estrogen are often assessed near the beginning of the menstrual cycle when the purpose is to evaluate baseline ovarian hormone patterns. Progesterone is usually assessed later, approximately 7 to 10 days after ovulation, when the question concerns whether ovulation has occurred. Because this panel contains both early-cycle and later-cycle hormones, the most appropriate sampling day depends on the clinical question.

Pregnancy and hormonal contraception

Pregnancy causes major physiological changes in estrogen, progesterone, thyroid-related hormones and cortisol. A possible or confirmed pregnancy must therefore be reported before interpretation. This panel is not a substitute for a pregnancy test or pregnancy-specific medical assessment.

Combined oral contraceptives, progestin-only contraception, hormonal intrauterine systems, implants, injections and menopausal hormone therapy can alter natural hormone patterns or suppress ovulation. The exact product, dose and timing of the last dose should be documented. Hormonal medication should not be stopped solely for testing unless this has been specifically advised.

Perimenopause and menopause

During perimenopause, FSH, LH, estrogen and progesterone may fluctuate considerably from one cycle to another. A single result may therefore not fully establish menopausal status. Age, menstrual history, symptoms and, when clinically appropriate, repeat testing provide a more reliable basis for interpretation. After menopause, different reference ranges are used because ovarian hormone production and pituitary feedback have changed.

How the test is performed

Step 1: Define the reason for testing

Before sampling, note the main symptoms, age, date of the last menstrual period, usual cycle length, cycle day, pregnancy status, menopausal status and use of hormonal contraception or hormone therapy. Previous thyroid or hormone results may also be useful.

Step 2: Plan the sampling time

A morning appointment is generally preferable because cortisol follows a strong daily rhythm and is normally highest in the morning. When menstrual-cycle interpretation is important, the sampling day should be selected according to the question being investigated.

Step 3: Venous blood sampling

A blood sample is taken from a vein in the arm and collected for laboratory analysis. The sampling itself usually takes only a few minutes. Normal activities can generally be resumed immediately afterward.

Step 4: Review the complete pattern

Results are generally available on the same day. Each value should be reviewed with the appropriate reference interval and in relation to the other hormones, symptoms and relevant medical history.

• Sample: venous blood
• Preferred timing: usually in the morning, with cycle timing selected according to the clinical purpose
• Procedure: brief outpatient blood draw
• Report: generally available the same day

What the results can show

The results may help identify a pattern consistent with altered thyroid function, changes in ovarian or pituitary hormone signaling, menopausal transition or an unexpected cortisol value. They may also show that measured hormones are within the reference ranges relevant to the recorded life stage.

An isolated result outside the reference range does not automatically confirm a disorder. Temporary illness, sleep disruption, emotional or physical stress, medication, hormonal treatment, time of sampling and cycle timing can all influence hormone levels. Further evaluation may include repeat measurements, additional laboratory tests, pregnancy testing, ultrasound or consultation with a gynecologist, endocrinologist or another appropriate specialist.

Practical next step through ZagrebMed

When sending an inquiry, include your age, symptoms, menstrual-cycle pattern, date of the last period, pregnancy status, menopausal status and details of hormonal contraception, hormone therapy, thyroid medication, corticosteroids and supplements. Previous hormone or thyroid reports can help clarify whether this broad panel or a more targeted test is the appropriate next step. ZagrebMed can help organize the laboratory service and connect the findings with a suitable consultation or further diagnostic pathway in Zagreb.